CME Group Inc. $CME Shares Bought by Truist Financial Corp

Truist Financial Corp raised its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 43.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 101,303 shares of the financial services provider's stock after purchasing an additional 30,591 shares during the period. Truist Financial Corp's holdings in CME Group were worth $27,664,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. Sanders Capital LLC purchased a new position in shares of CME Group in the third quarter valued at approximately $1,006,932,000. Strive Asset Management LLC purchased a new position in shares of CME Group in the third quarter valued at approximately $636,487,000. Mawer Investment Management Ltd. lifted its position in shares of CME Group by 107.2% in the third quarter. Mawer Investment Management Ltd. now owns 1,502,752 shares of the financial services provider's stock valued at $406,029,000 after acquiring an additional 777,571 shares in the last quarter. Viking Global Investors LP purchased a new position in shares of CME Group in the second quarter valued at approximately $164,648,000. Finally, Vanguard Group Inc. lifted its position in shares of CME Group by 1.7% in the fourth quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider's stock valued at $9,802,366,000 after acquiring an additional 588,509 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Trading Down 1.2%

Shares of CME stock opened at $286.82 on Wednesday. The company has a 50-day moving average of $302.66 and a two-hundred day moving average of $286.95. The firm has a market cap of $103.93 billion, a PE ratio of 24.47, a price-to-earnings-growth ratio of 3.51 and a beta of 0.23. CME Group Inc. has a 1-year low of $257.17 and a 1-year high of $329.16. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.11 by $0.25. The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business's revenue was up 14.5% on a year-over-year basis. During the same period in the previous year, the firm earned $2.80 EPS. On average, analysts predict that CME Group Inc. will post 12.26 EPS for the current year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 26th. Investors of record on Tuesday, March 10th were issued a $1.30 dividend. The ex-dividend date was Tuesday, March 10th. This represents a $5.20 annualized dividend and a dividend yield of 1.8%. This is a boost from CME Group's previous quarterly dividend of $1.25. CME Group's dividend payout ratio (DPR) is presently 44.37%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on CME shares. TD Cowen reduced their price objective on CME Group from $340.00 to $323.00 and set a "buy" rating on the stock in a research report on Thursday, April 23rd. Erste Group Bank upgraded CME Group from a "hold" rating to a "strong-buy" rating in a research report on Thursday, March 5th. Morgan Stanley reduced their price objective on CME Group from $362.00 to $353.00 and set an "overweight" rating on the stock in a research report on Thursday, April 23rd. Weiss Ratings upgraded CME Group from a "buy (b+)" rating to a "buy (a-)" rating in a research report on Monday, March 2nd. Finally, Jefferies Financial Group reduced their price objective on CME Group from $356.00 to $349.00 and set a "buy" rating on the stock in a research report on Thursday, April 9th. Two investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat, CME Group presently has a consensus rating of "Moderate Buy" and an average price target of $305.29.

Insider Transactions at CME Group

In related news, Director Dennis Suskind sold 748 shares of the business's stock in a transaction on Friday, February 6th. The stock was sold at an average price of $300.00, for a total value of $224,400.00. Following the sale, the director owned 2,699 shares in the company, valued at approximately $809,700. The trade was a 21.70% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Bryan T. Durkin sold 4,200 shares of the business's stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $309.65, for a total value of $1,300,530.00. Following the completion of the sale, the director owned 43,007 shares in the company, valued at $13,317,117.55. This represents a 8.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 8,539 shares of company stock worth $2,713,821 over the last quarter. 0.30% of the stock is owned by corporate insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.